- Valuation
- ₹11,600 Cr

About Bharat Biotech
Bharat Biotech is a Healthcare company based in Hyderabad (India) founded in 1996 by Suchitra Ella and Krishna Ella. Bharat Biotech has raised $13.74 million across 6 funding rounds from investors including International Finance Corporation, Gates Foundation and CEPI. The company has 2,776 employees. Bharat Biotech has completed 1 acquisition, including Chiron Behring India. Its chief executive, as recorded, is Ajayreddy Parakala. Its website bharatbiotech.com draws about 31 thousand monthly visits. Its Indian entity Bharat Biotech International Limited reported revenue of βΉ1,630 Cr. Bharat Biotech offers products and services including COVAXIN, ROTAVAC, and Typbar TCV. Its focus areas include Life Sciences, Immunotherapy, Vaccine and Prophylactic.
Company details
Manufacturer of vaccines and bio-therapeutic products. It offers a portfolio of products which includes a broad range of vaccines and therapeutics for Hepatitis B, Polio, Rabies, Typhoid, tetanus, pertussis,, and Haemophilus influenzae type b. It also provide topical medicines for wounds, burns, ulcers, and others.
Recognitions & Rankings of Bharat Biotech
- Headquarters Hyderabad, India
- Employees 2,776
- Founders Suchitra Ella, Krishna Ella
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website bharatbiotech.com
- Social LinkedIn X Facebook
- Legal Name Bharat Biotech International Limited
- Date of Incorporation 15 Feb, 1996
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1,630 Cr
FY 2025 · +4% YoY
- Net Profit₹341 Cr
FY 2025 · 23% margin
- EBITDA₹609 Cr
FY 2025 · 42% margin
- Total Equity Funding$13.74M (USD)
in 6 rounds
- InvestorsInternational Finance Corporation
& 4 more
- Employee Count2,776
- Investments & Acquisitions
Associated legal entities of Bharat Biotech
Bharat Biotech is associated with 2 registered companies on The Company Check; the primary company is Bharat Biotech International Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bharat Biotech International Limited CIN U24230TG1996PLC023232 | Active | 15 Feb 1996 | Hyderabad, Telangana | ₹1,630 Cr | 1,286 | 9 | View details |
| Skegen Asset Management Llp CIN ABB-9283 | Active | 01 Aug 2022 | Bangalore, Karnataka | 2 | View details |
Products & Services of Bharat Biotech
Bharat Biotech offers a comprehensive portfolio of products and services, including COVAXIN, ROTAVAC, and Typbar TCV.
Vaccine for COVID-19 prevention and protection.
Rotavirus vaccine for preventing childhood diarrhea.
Typhoid conjugate vaccine for long-term immunity.
Funding Insights of Bharat Biotech
Bharat Biotech has successfully raised a total of $13.74M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.74M
- Total Rounds 6
- Investors Count 5
All 6 funding rounds of Bharat Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2020 | Grant | β | β | ||
| Jun 2015 | $18.5M | Grant | β | β | |
| May 2010 | $64,322 | Grant | β | β | |
| Jun 2007 | $6M | Private Equity Round | β | IFC | β |
| Jun 2006 | $7.74M | Private Equity Round | β | ICICI Venture | β |
| Jun 2005 | Private Equity Round | β | ICICI Venture | β |
5 investors in total: 5 institutional.
Investors in Bharat Biotech
Bharat Biotech has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include International Finance Corporation, Gates Foundation and CEPI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare investments are targeted by this private equity firm. | 2017 | cepi.net | Oslo, Norway | |
IFC is focused on private sector development in emerging markets. | 1956 | ifc.org | ||
Alternative asset management and investment services in India. | 1988 | iciciventure.com | Mumbai, India | |
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States | |
Biotechnology research, guidelines, and funding by the Government of India. | 1986 | dbtindia.gov.in | Delhi, India |
Investor details for Bharat Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Bharat Biotech International Limited (Bharat Biotech)
Bharat Biotech International Limited is the primary company behind Bharat Biotech. The boards of the 2 registered companies of Bharat Biotech currently have 8 directors; the longest-serving is Prathivadibhayankaram Ranganathac Rajagopalan, appointed in 1998. 27 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prathivadibhayankaram Ranganathac Rajagopalan DIN 03272757 | Director | 30 Sep 1998 | 28 yrs 1 mo | Bharat Biotech International Limited |
| Suchitra Ella DIN 00090616 | Managing Director | 25 Sep 2007 | 19 yrs 1 mo | Bharat Biotech International Limited |
| Krishna Mohan Vadrevu DIN 05222871 | Whole-time director | 28 Dec 2011 | 14 yrs 10 mo | Bharat Biotech International Limited |
| Velagapudi Kavitha Dutt DIN 00139274 | Director | 20 Mar 2020 | 6 yrs 8 mo | Bharat Biotech International Limited |
| Sai Prasad Devarajulu DIN 02790648 | Whole-time director | 02 Sep 2020 | 6 yrs 2 mo | Bharat Biotech International Limited |
| Jalachari Ella DIN 07792035 | Designated Partner | 01 Aug 2022 | 4 yrs 3 mo | Skegen Asset Management Llp |
| Krishna Murthy Ella DIN 00072071 | Designated Partner | 01 Aug 2022 | 4 yrs 3 mo | Skegen Asset Management Llp, Bharat Biotech International Limited |
| Venkateswarlu Jasti DIN 00278028 | Additional Director | 19 Jan 2026 | 9 mo | Bharat Biotech International Limited |
People of Bharat Biotech
33 people are tracked at Bharat Biotech (13 in leadership, 20 in team); the tracked headcount is 2,776.
| Name | Role | Group |
|---|---|---|
| Co-Founder & Managing Director | Leadership | |
| Co-Founder & Managing Director | Leadership | |
Ajayreddy Parakala | CEO | Leadership |
V Krishna Mohan | Executive Director | Leadership |
T Srinivas | Chief Financial Officer | Leadership |
Sumathy K | Head – R&D | Leadership |
Shareef Mahaboob | Head Of Sales Marketing | Leadership |
Tadepally Srinivas | Vice President | Leadership |
Umesh Joshi | Deputy General Manager | Leadership |
Srinivas Tadepally | CFO | Leadership |
Dr.bhargava Ram | Assistant General Manager | Leadership |
Sujana Prasad Chittineni | Deputy General Manager | Leadership |
Badri Patnaik | Head Clinical Developwmnt | Leadership |
Sundaram P A | Deputy Manager | Team |
Pankaj Kumar Patel Patel | Lead - Technical Operationa And Product Services | Team |
Sridhar Reddy Kaasam | Manager | Team |
Ramesh Rangaiah | Marketing And Business Development Manager | Team |
Fathey Mohammed | Senior Manager HR & Admin | Team |
Laxmirajam Bandi | Deputy Manager | Team |
Praveen Jadhav | Production Team Member | Team |
13 more people are available in the full profile.
Complete people profiles for Bharat Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Bharat Biotech
Figures of Bharat Biotech International Limited, the primary company behind Bharat Biotech, for FY 2025. Revenue was ₹1,630 Cr (+4% year on year). Net profit was ₹341 Cr (23% margin). EBITDA was ₹609 Cr (42% margin). Revenue has grown at a compounded annual rate of -41% over three years and +9% over five years.
- ₹1,630 CrRevenue · FY 2025 · +4% YoY
- ₹341 CrNet profit · 23% margin
- ₹609 CrEBITDA · 42% margin
- ₹78.19 CrPaid-up capital
- 1,286Employees (provident fund records)
- -41%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bharat Biotech International Limited are on its company page.
Detailed financial statements for Bharat Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bharat Biotech
Bharat Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Chiron Behring India.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Limited information available | chironbehring-india.com | Ankleshwar, India | 0 | Feb 2019 | β’β’β’β’ |
Complete acquisition details for Bharat Biotech
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Bharat Biotech
4 dated milestones of Bharat Biotech across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Bharat Biotech is founded.
- Funding First funding round.
- Acquisition Acquires Chiron Behring India.
- Funding Latest funding round, Grant,.
Web traffic of Bharat Biotech
The website of Bharat Biotech (bharatbiotech.com) receives about 30.6K visits a month and ranks #736,609 among all websites worldwide, #844 in Biotechnology and Pharmaceuticals.
- Monthly visits30.6K
▲ 8.6% vs previous month
- Unique visitors14.6K
per month
- Global rank#736,609
among all websites
- Category rank#844
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit4.7
- Average visit2 min 10 sec
- DevicesDesktop 34% Β· Mobile 66%
Websites whose visitors overlap most with Bharat Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bsvgroup.com | 100% | 7.2K | #3,563,176 | View details | |
| seruminstitute.com | 99% | 63.5K | #656,121 | View details | |
ip.mountsinai.org | ip.mountsinai.org | 97% | β | ||
| virchowbiotech.com | 94% | 1.4K | #4,149,585 | View details | |
| vical.com | 89% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 20 similar websites and full traffic analytics for Bharat Biotech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bharat Biotech
Complete news archive for Bharat Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bharat Biotech
Bharat Biotech was founded in 1996 and raised its 1st funding round 9 years after it was founded.
Bharat Biotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Ajayreddy Parakala is the CEO of Bharat Biotech, as recorded in our data.
Bharat Biotech is a funded company, having raised a total of $13.74M across 6 funding rounds to date.
Bharat Biotech has 2,776 employees.
The primary company behind Bharat Biotech, Bharat Biotech International Limited, reported revenue of βΉ1,630 Cr for FY 2025, up 4% year on year.
Manufacturer of vaccines and bio-therapeutic products. It offers a portfolio of products which includes a broad range of vaccines and therapeutics for Hepatitis B, Polio, Rabies, Typhoid, tetanus, pertussis,, and Haemophilus influenzae type b. It also provide topical medicines for wounds, burns, ulcers, and others.
Bharat Biotech offers COVAXIN, ROTAVAC, and Typbar TCV.
Bharat Biotech has made 1 acquisition, including Chiron Behring India.
Bharat Biotech has 5 investors. Key investors include International Finance Corporation, Gates Foundation, CEPI, ICICI Venture, and Department of Biotechnology.
Bharat Biotech is associated with 2 legal entities: Bharat Biotech International Limited, Skegen Asset Management Llp.
The legal entities of Bharat Biotech currently have 10 directors, including Jalachari Ella, Krishna Murthy Ella, Krishna Mohan Vadrevu and others.
